Total Payments
$2,390
2024 Payments
$290.26
Companies
23
Transactions
59
Medicare Patients
5,393
Medicare Billing
$674,709
Payment Breakdown by Category
Food & Beverage$2,390 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,390 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $659.80 | 9 | $0 (2023) |
| Lilly USA, LLC | $262.90 | 6 | $0 (2024) |
| Celgene Corporation | $145.80 | 2 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $133.55 | 6 | $0 (2020) |
| UCB, Inc. | $125.00 | 1 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $122.00 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $121.60 | 1 | $0 (2023) |
| ABBVIE INC. | $106.17 | 6 | $0 (2024) |
| Medtronic USA, Inc. | $102.26 | 1 | $0 (2019) |
| Allergan, Inc. | $95.54 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $290.26 | 6 | UCB, Inc. ($125.00) |
| 2023 | $473.49 | 8 | Celgene Corporation ($130.00) |
| 2022 | $264.24 | 9 | Biogen, Inc. ($161.62) |
| 2021 | $118.62 | 7 | Novartis Pharmaceuticals Corporation ($37.53) |
| 2020 | $70.31 | 4 | Sunovion Pharmaceuticals Inc. ($42.03) |
| 2019 | $736.43 | 14 | Biogen, Inc. ($358.19) |
| 2018 | $273.19 | 4 | Biogen, Inc. ($117.60) |
| 2017 | $163.55 | 7 | Abbott Laboratories ($55.38) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: PAIN | ||||||
| 07/15/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Neuroscience | ||||||
| 06/05/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $86.75 | General |
| 05/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 10/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Neuroscience | ||||||
| 07/25/2023 | Abbott Laboratories | PENTA (Device) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Neuromodulation | ||||||
| 06/22/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: VACCINES | ||||||
| 06/06/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $130.00 | General |
| Category: Neuroscience | ||||||
| 05/11/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/16/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $122.00 | General |
| Category: NEUROLOGY | ||||||
| 03/07/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Neurology | ||||||
| 11/18/2022 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Neurology | ||||||
| 09/14/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/07/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Rare Disease | ||||||
| 08/30/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.80 | General |
| Category: Neuroscience | ||||||
| 08/17/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Rare Disease | ||||||
| 06/15/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Neuroscience | ||||||
| 05/06/2022 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Neurology | ||||||
| 03/31/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $94.32 | General |
| 03/23/2022 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Neurology | ||||||
| 11/23/2021 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,247 | 13,561 | $402,869 | $173,969 |
| 2022 | 14 | 1,276 | 10,656 | $353,667 | $171,312 |
| 2021 | 19 | 1,435 | 12,420 | $392,015 | $171,720 |
| 2020 | 19 | 1,435 | 13,588 | $390,026 | $157,709 |
Total Patients
5,393
Total Services
50,225
Medicare Billing
$674,709
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 19 | 9,400 | $75,200 | $46,648 | 62.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 361 | 454 | $73,548 | $41,390 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 389 | 498 | $51,294 | $30,680 | 59.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 94 | 118 | $28,202 | $15,585 | 55.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 111 | 111 | $30,081 | $12,525 | 41.6% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 27 | 27 | $35,991 | $4,278 | 11.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $9,724 | $3,620 | 37.2% |
| 73721 | Mri scan of leg joint without contrast | Office | 2023 | 15 | 17 | $22,661 | $2,864 | 12.6% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 18 | 18 | $23,994 | $2,698 | 11.2% |
| 73221 | Mri scan of arm joint without contrast | Office | 2023 | 15 | 16 | $21,328 | $2,577 | 12.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 38 | 55 | $6,985 | $2,567 | 36.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 19 | 19 | $7,163 | $2,232 | 31.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 22 | 22 | $6,292 | $2,026 | 32.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $4,238 | $1,996 | 47.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 16 | 19 | $3,325 | $1,298 | 39.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 22 | $1,628 | $672.45 | 41.3% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 18 | 2,700 | $1,215 | $311.37 | 25.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 16 | 9,100 | $72,800 | $44,585 | 61.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 316 | 429 | $69,498 | $40,260 | 57.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 451 | 595 | $61,285 | $37,817 | 61.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 150 | 150 | $28,050 | $12,098 | 43.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 59 | $14,101 | $7,528 | 53.4% |
| 70551 | Mri scan of brain without contrast | Office | 2022 | 39 | 39 | $51,987 | $6,152 | 11.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 44 | 44 | $12,584 | $4,956 | 39.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 50 | 58 | $10,150 | $4,711 | 46.4% |
About Dr. Stephen Penny, MD
Dr. Stephen Penny, MD is a Neurology healthcare provider based in Dover, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881691236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Penny, MD has received a total of $2,390 in payments from pharmaceutical and medical device companies, with $290.26 received in 2024. These payments were reported across 59 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,390).
As a Medicare-enrolled provider, Penny has provided services to 5,393 Medicare beneficiaries, totaling 50,225 services with total Medicare billing of $674,709. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Dover, DE
- Active Since 06/30/2005
- Last Updated 01/29/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1881691236
Products in Payments
- ZEPOSIA (Drug) $145.80
- Rystiggo (Drug) $125.00
- XYWAV (Drug) $122.00
- REXULTI (Drug) $121.60
- TECFIDERA (Drug) $118.11
- APTIOM (Drug) $111.40
- BOTOX (Biological) $102.53
- ACTIVA (Device) $102.26
- VUMERITY (Drug) $89.69
- NUEDEXTA (Drug) $79.65
- UBRELVY (Drug) $54.45
- EMGALITY (Drug) $54.35
- AJOVY (Drug) $53.59
- Aimovig (Biological) $43.59
- SCS leads (Device) $41.16
- KESIMPTA (Drug) $37.53
- ULTOMIRIS (Biological) $35.62
- Zinbryta (Biological) $32.90
- Non-Covered Product (Drug) $29.33
- AUBAGIO (Drug) $26.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Dover
Abraham Scheer, Md, MD
Neurology — Payments: $230,940
Neurology $230,940
Alok Bhagat, M.d, M.D
Neurology — Payments: $8,427
Neurology $8,427
Wayne Greene, Md, MD
Neurology — Payments: $4,869
Neurology $4,869
Marcia Dover, Md, MD
Neurology — Payments: $4,402
Neurology $4,402
Dr. Robert Varipapa, M.d, M.D
Neurology — Payments: $3,196
Neurology $3,196
Infanta Stephen, Md, MD
Neurology — Payments: $2,240
Neurology $2,240